AU2260588A - Molecular cloning of human rotavirus serotype 4 gene 9 encoding vp7, the major outer capsid neutralisation specific glycoprotein and expression of vp7 and fragments thereof for use in a vaccine - Google Patents

Molecular cloning of human rotavirus serotype 4 gene 9 encoding vp7, the major outer capsid neutralisation specific glycoprotein and expression of vp7 and fragments thereof for use in a vaccine

Info

Publication number
AU2260588A
AU2260588A AU22605/88A AU2260588A AU2260588A AU 2260588 A AU2260588 A AU 2260588A AU 22605/88 A AU22605/88 A AU 22605/88A AU 2260588 A AU2260588 A AU 2260588A AU 2260588 A AU2260588 A AU 2260588A
Authority
AU
Australia
Prior art keywords
neutralisation
vaccine
fragments
gene
encoding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU22605/88A
Other versions
AU621065B2 (en
Inventor
Michael Leigh Dyall-Smith
Ian Hamilton Holmes
Chris Hum
Michael Anthony Johnson
Peter Richard Reeves
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SYDNEY THE, University of
University of Melbourne
Original Assignee
Sydney The, University of
University of Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sydney The, University of, University of Melbourne filed Critical Sydney The, University of
Priority to AU22605/88A priority Critical patent/AU621065B2/en
Priority claimed from PCT/AU1988/000298 external-priority patent/WO1989001514A1/en
Publication of AU2260588A publication Critical patent/AU2260588A/en
Application granted granted Critical
Publication of AU621065B2 publication Critical patent/AU621065B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU22605/88A 1987-08-10 1988-08-10 Molecular cloning of human rotavirus serotype 4 gene 9 encoding vp7, the major outer capsid neutralisation specific glycoprotein and expression of vp7 and fragments thereof for use in a vaccine Expired AU621065B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU22605/88A AU621065B2 (en) 1987-08-10 1988-08-10 Molecular cloning of human rotavirus serotype 4 gene 9 encoding vp7, the major outer capsid neutralisation specific glycoprotein and expression of vp7 and fragments thereof for use in a vaccine

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPI364387 1987-08-10
AUPI3643 1987-08-10
AU22605/88A AU621065B2 (en) 1987-08-10 1988-08-10 Molecular cloning of human rotavirus serotype 4 gene 9 encoding vp7, the major outer capsid neutralisation specific glycoprotein and expression of vp7 and fragments thereof for use in a vaccine
PCT/AU1988/000298 WO1989001514A1 (en) 1987-08-10 1988-08-10 Molecular cloning of human rotavirus serotype 4 gene 9 encoding vp7, the major outer capsid neutralisation specific glycoprotein and expression of vp7 and fragments thereof for use in a vaccine

Publications (2)

Publication Number Publication Date
AU2260588A true AU2260588A (en) 1989-03-09
AU621065B2 AU621065B2 (en) 1992-03-05

Family

ID=31891613

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22605/88A Expired AU621065B2 (en) 1987-08-10 1988-08-10 Molecular cloning of human rotavirus serotype 4 gene 9 encoding vp7, the major outer capsid neutralisation specific glycoprotein and expression of vp7 and fragments thereof for use in a vaccine

Country Status (1)

Country Link
AU (1) AU621065B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114478714A (en) * 2022-02-04 2022-05-13 通化师范学院 Method for analyzing expression and immunogenicity of recombinant human rotavirus VP7 protein

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5736286A (en) * 1985-05-14 1986-11-20 Commonwealth Scientific And Industrial Research Organisation Rotavirus antigens
EP0251467A3 (en) * 1986-06-20 1988-07-20 Abbott Laboratories Compositions and methods of use for a major outer capsid protein (vp7) of rotavirus sa-11
US5186933A (en) * 1986-12-30 1993-02-16 Baylor College Of Medicine Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114478714A (en) * 2022-02-04 2022-05-13 通化师范学院 Method for analyzing expression and immunogenicity of recombinant human rotavirus VP7 protein

Also Published As

Publication number Publication date
AU621065B2 (en) 1992-03-05

Similar Documents

Publication Publication Date Title
PL339735A1 (en) Pappiloma virus capsomer vaccine compositions and methods of applying them
EP0402354A4 (en) Molecular cloning of human rotavirus serotype 4 gene 9 encoding vp7, the major outer capsid neutralisation specific glycoprotein and expression of vp7 and fragments thereof for use in a vaccine
EP0757717A4 (en) Papillomavirus vaccines
AU7966987A (en) Empty viral capsid vaccines
AU5166693A (en) Endotracheal tube for face, chin and neck surgery
EP0467700A3 (en) Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties
EP0681585A4 (en) Tata-binding protein associated factors, nucleic acids encoding tafs, and methods of use.
AU1255383A (en) Foot and mouth disease viral antigenic peptides
IL117115A (en) Process for preparing recombinant adenovirus genomes
IL93957A0 (en) Bordetella outer membrane proteins,their use in vaccines and their expression
AU1927797A (en) Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines
EP0888777A3 (en) Recombinant bovine herpesvirus type 1 polyptpetides and vaccines
HUP9901035A3 (en) Parapoxviruses containing foreign dna, their production and their use in vaccines
EP0265457A4 (en) Vaccine and implant.
EP0187722A3 (en) Antibiotics called "chloropolysporins b and c", a process for their preparation, and their therapeutic and veterinary use
AU2260588A (en) Molecular cloning of human rotavirus serotype 4 gene 9 encoding vp7, the major outer capsid neutralisation specific glycoprotein and expression of vp7 and fragments thereof for use in a vaccine
NZ239948A (en) Hiv gp160 modified at positions 502 and 510, vaccines and recombinant methods for producing modified gp160
EP0110791A3 (en) Peptides containing an immunogenic site of the poliovirus, and dna's containing nucleotide fragments encoding for these peptides
AU3065892A (en) Pneumococcal fimbrial protein a vaccines
AR243237A1 (en) Human ciliary neuronotrophic factor, dna sequence encoding the factor, and production of the factor by recombinant technology
EP0474676A4 (en) Production of ibdv vp2 in highly immunogenic form
DK575787A (en) Recombinant HCMV-derived plasmid, its preparation and use
IL112993A0 (en) Recombinant niruses, their preparation and their use in gene therapy
AU1825895A (en) Retroviral vaccines, vaccination and immune-therapy for retroviral infections
AU697814B2 (en) Improvements in sustainable cell line for the production of Marek's disease vaccines